Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Renal Insufficiency, Chronic × Quillaja Saponins × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Renal Insufficiency, Chronic 1

Interventions

venetoclax 1 saponin QA-21V1 1 finerenone 1 empagliflozin 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Quillaja Saponins 1 Protein Subunit Vaccines 1 Practice Guidelines as Topic 1 Phlebotomy 1 Kidney Transplantation 1 Hypothermia, Induced 1 High-Energy Shock Waves 1 Eplerenone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06741072 2026-01-08

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Ohio State University Comprehensive Cancer Center

Phase 1 Suspended

Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡